Institute Pasteur Korea and Euroscreen Ink GPCR Drug-Discovery Deal

Feb 27, 2006

NEW YORK, Feb. 27 (GenomeWeb News) - The Institute Pasteur Korea and Euroscreen will collaborate in GPCR screening, the partners announced today.

Under the deal, Euroscreen will provide receptor cell lines and GPCR library compounds for analysis on IPK's high-throughput screening platform.

Additional details were not provided.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.